Managers / Q1 2022 · view latest →
Telemetry Investments, L.L.C.
CIK 0001537055 · 152 WEST 36TH STREET, ROOM 402, NEW YORK, NY, 10018-8765 · 212-425-9700
Reported Value
$63M
Q1 2022
Positions
165
Filings on Record
17
2019–present window
Filed
May 16, 2022
original filing
Summary
Telemetry Investments, L.L.C. reported $63M in U.S.-listed holdings across 165 positions for Q1 2022.
Its largest position, Silver Spike Acquisitn, represents 4.4% of the portfolio.
Compared with Q4 2021, the fund opened 48 new positions and exited 60.
Portfolio Metrics
Turnover
+36.8%
vs prior filed quarter
Top-10 Concentration
+27.0%
share of reported value
Largest Position
+4.4%
Silver Spike Acquisitn
New / Exited
48 / 60
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 47.1% · $30M
- Other · 35.6% · $23M
- ETP · 10.9% · $7M
- ADR · 4.7% · $3M
- REIT · 1.4% · $891,000
- Equity WRT · 0.4% · $231,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| XLESELECT SECTOR SPDR TR | NEW | +25.0K | 25.0K | +$2M | $2M |
| CERNER CORP | NEW | +14.0K | 14.0K | +$1M | $1M |
| TRAJECTORY ALPHA ACQUISITION | NEW | +106.0K | 106.0K | +$1M | $1M |
| SHUAA PARTNERS ACQUISTN CORP | NEW | +100.0K | 100.0K | +$1M | $1M |
| BATTERY FUTURE ACQUISITION C | NEW | +89.3K | 89.3K | +$884,000 | $884,000 |
| HEALTHCARE AI ACQUISITION CO | NEW | +83.9K | 83.9K | +$831,000 | $831,000 |
| POWERUP ACQUISITION CORP | NEW | +80.0K | 80.0K | +$804,000 | $804,000 |
| VALUENCE MERGER CORP I | NEW | +80.0K | 80.0K | +$802,000 | $802,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2022
148 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SILVER SPIKE ACQUISITN CORP | CLASS A ORD SHS · *W EXP 02/26/202 | 4.35% | $3M | 336.2K |
| 2 | ANGEL POND HOLDINGS CORP | SHS CL A · *W EXP 99/99/999 | 3.14% | $2M | 315.8K |
| 3 | XLESELECT SECTOR SPDR TRhistory → | ENERGY | 3.02% | $2M | 25.0K |
| 4 | ACTIVISION BLIZZARD INC | COM | 2.97% | $2M | 23.5K |
| 5 | EIGER BIOPHARMACEUTICALS INC | COM | 2.79% | $2M | 213.0K |
| 6 | ATYRATYR PHARMA INChistory → | COM NEW | 2.38% | $2M | 282.4K |
| 7 | PEOPLES UNITED FINANCIAL INC | COM | 2.35% | $1M | 74.5K |
| 8 | FXIISHARES TR | CHINA LG-CAP ETF · US AER DEF ETF · GL CLEAN ENE ETF | 2.17% | $1M | 40.5K |
| 9 | CERNER CORP | COM | 2.06% | $1M | 14.0K |
| 10 | COHERENT INC | COM | 1.73% | $1M | 4.0K |
| 11 | PARATEK PHARMACEUTICALS INC | COM | 1.70% | $1M | 363.0K |
| 12 | TRAJECTORY ALPHA ACQUISITION | COM CL A · *W EXP 99/99/999 | 1.66% | $1M | 159.0K |
| 13 | SHUAA PARTNERS ACQUISTN CORP | UNIT 02/24/2027 | 1.58% | $1M | 100.0K |
| 14 | XBISPDR SER TRhistory → | S&P BIOTECH | 1.56% | $989,000 | 11.0K |
| 15 | HOME PLATE ACQUISITION CORP | CL A COM · *W EXP 09/30/202 | 1.55% | $982,000 | 148.4K |
| 16 | GANXGAIN THERAPEUTICS INChistory → | COM | 1.55% | $979,000 | 240.0K |
| 17 | MSOSADVISORSHARES TRhistory → | PURE US CANNABIS | 1.50% | $953,000 | 45.7K |
| 18 | WTWWILLIS TOWERS WATSON PLC LTDhistory → | SHS | 1.49% | $945,000 | 4.0K |
| 19 | BATTERY FUTURE ACQUISITION C | CL A ORD SHS · *W EXP 99/99/999 | 1.41% | $896,000 | 133.9K |
| 20 | DISDISNEY WALT COhistory → | COM | 1.41% | $893,000 | 6.5K |
| 21 | BKOBLUEROCK RESIDENTIAL GWT REIhistory → | COM CL A | 1.41% | $891,000 | 33.5K |
| 22 | HEALTHCARE AI ACQUISITION CO | CLASS A ORD SHS · *W EXP 99/99/999 | 1.32% | $838,000 | 125.8K |
| 23 | POWERUP ACQUISITION CORP | UNIT 02/18/2032 | 1.27% | $804,000 | 80.0K |
| 24 | VALUENCE MERGER CORP I | UNIT 02/18/2027 | 1.27% | $802,000 | 80.0K |
| 25 | WELBILT INC | COM | 1.26% | $800,000 | 33.7K |
| 26 | HEALTHWELL ACQUISITION CORP | CLASS A COM · *W EXP 08/05/202 | 1.23% | $778,000 | 177.9K |
| 27 | BABAALIBABA GROUP HLDG LTDhistory → | SPONSORED ADS | 1.17% | $744,000 | 6.8K |
| 28 | AMRYT PHARMA PLC | SPONSORED ADS | 1.14% | $723,000 | 87.6K |
| 29 | VACCINEX INC | COM | 1.13% | $713,000 | 540.0K |
| 30 | PORTWSOUTHPORT ACQUISITION CORP | CL A COM · *W EXP 99/99/999 | 1.11% | $704,000 | 105.0K |
| 31 | FAST ACQUISITION CORP II | CL A | 1.07% | $677,000 | 69.4K |
| 32 | PERSHING SQUARE TONTINE HLDG | COM CL A | 1.07% | $676,000 | 34.0K |
| 33 | TGNATEGNA INChistory → | COM | 1.06% | $672,000 | 30.0K |
| 34 | BOTTOMLINE TECH DEL INC | COM | 1.06% | $670,000 | 11.8K |
| 35 | BIOPLUS ACQUISITION CORP | CLASS A ORD SHS · *W EXP 12/02/202 | 1.05% | $665,000 | 99.9K |
| 36 | SHELSHELL PLChistory → | SPON ADS | 1.04% | $659,000 | 12.0K |
| 37 | INTELLIGENT MEDI ACQSITN COR | UNIT 11/05/2026 | 0.98% | $620,000 | 61.3K |
| 38 | PARAMOUNT GLOBAL | CLASS B COM | 0.97% | $616,000 | 16.3K |
| 39 | AFFIMED N V | COM | 0.97% | $612,000 | 140.0K |
| 40 | GRAF ACQUISITION CORP IV | COM | 0.91% | $578,000 | 59.6K |
| 41 | CCITIGROUP INC | COM NEW | 0.91% | $577,000 | 10.8K |
| 42 | MIRMIRION TECHNOLOGIES INC | COM CL A | 0.87% | $553,000 | 68.5K |
| 43 | ROGROGERS CORP | COM | 0.86% | $543,000 | 2.0K |
| 44 | VRAYQVIEWRAY INC | COM | 0.85% | $539,000 | 137.5K |
| 45 | FOUNDER SPAC | CLASS A ORD SHS · *W EXP 04/19/202 | 0.82% | $518,000 | 88.1K |
| 46 | EVAXION BIOTECH A S | ADS | 0.81% | $515,000 | 168.7K |
| 47 | BRICKELL BIOTECH INC | COM | 0.80% | $510,000 | 1.91M |
| 48 | CITRIX SYS INC | COM | 0.78% | $494,000 | 4.9K |
| 49 | FCXFREEPORT-MCMORAN INC | CL B | 0.75% | $473,000 | 9.5K |
| 50 | CRVSCORVUS PHARMACEUTICALS INC | COM | 0.74% | $472,000 | 287.5K |
| 51 | GLDSPDR GOLD TR | GOLD SHS | 0.71% | $452,000 | 2.5K |
| 52 | BP MIDSTREAM PARTNERS LP | UNIT LTD PTNR | 0.70% | $445,000 | 26.3K |
| 53 | ADMAADMA BIOLOGICS INC | COM | 0.67% | $425,000 | 232.5K |
| 54 | FHNFIRST HORIZON CORPORATION | COM | 0.65% | $413,000 | 17.6K |
| 55 | BPBP PLC | SPONSORED ADR | 0.65% | $412,000 | 14.0K |
| 56 | TENNECO INC | CL A VTG COM STK | 0.65% | $409,000 | 22.3K |
| 57 | CCMPCMC MATERIALS INC | COM | 0.64% | $408,000 | 2.2K |
| 58 | RIGEL PHARMACEUTICALS INC | COM NEW | 0.64% | $404,000 | 135.0K |
| 59 | BRIDGETOWN HOLDINGS LTD | COM CL A | 0.64% | $404,000 | 41.0K |
| 60 | SCYNEXIS INC | COM NEW | 0.60% | $379,000 | 97.0K |
| 61 | TANINVESCO EXCH TRADED FD TR II | SOLAR ETF | 0.60% | $377,000 | 5.0K |
| 62 | NEOPHOTONICS CORP | COM | 0.58% | $365,000 | 24.0K |
| 63 | COHN ROBBINS HOLDINGS CORP | COM CL A · *W EXP 08/28/202 | 0.57% | $361,000 | 202.4K |
| 64 | TAT&T INC | COM | 0.56% | $354,000 | 15.0K |
| 65 | AMDADVANCED MICRO DEVICES INC | COM | 0.56% | $353,000 | 3.2K |
| 66 | LISTED FD TR | ROUNDHILL SPORTS | 0.54% | $340,000 | 17.0K |
| 67 | ACRSACLARIS THERAPEUTICS INC | COM | 0.52% | $328,000 | 19.0K |
| 68 | EENI S P A | SPONSORED ADR | 0.51% | $322,000 | 11.0K |
| 69 | TSEMTOWER SEMICONDUCTOR LTD | SHS NEW | 0.50% | $315,000 | 6.5K |
| 70 | MAKEMYTRIP LIMITED MAURITIUS | SHS | 0.49% | $309,000 | 11.5K |
| 71 | GMGENERAL MTRS CO | COM | 0.48% | $307,000 | 7.0K |
| 72 | TTENTOTALENERGIES SE | SPONSORED ADS | 0.48% | $303,000 | 6.0K |
| 73 | MUSTANG BIO INC | COM | 0.47% | $300,000 | 297.5K |
| 74 | QCLNFIRST TR EXCHANGE-TRADED FD | NAS CLNEDG GREEN | 0.46% | $291,000 | 4.5K |
| 75 | MSFTMICROSOFT CORP | COM | 0.44% | $277,000 | 900 |
| 76 | SOUTH JERSEY INDS INC | COM | 0.44% | $276,000 | 8.0K |
| 77 | TECKTECK RESOURCES LTD | CL B | 0.42% | $263,000 | 6.5K |
| 78 | VONAGE HLDGS CORP | COM | 0.40% | $255,000 | 12.5K |
| 79 | MONEYGRAM INTL INC | COM NEW | 0.39% | $248,000 | 23.5K |
| 80 | CONTRAFECT CORP | COM NEW | 0.39% | $245,000 | 67.0K |
| 81 | WLLWHITING PETE CORP NEW | COM NEW | 0.39% | $245,000 | 3.0K |
| 82 | NIELSEN HLDGS PLC | SHS EUR | 0.39% | $245,000 | 9.0K |
| 83 | URAGLOBAL X FDS | GLOBAL X URANIUM | 0.37% | $235,000 | 9.0K |
| 84 | MTORMERITOR INC | COM | 0.36% | $231,000 | 6.5K |
| 85 | DISCOVERY INC | COM SER A | 0.35% | $224,000 | 9.0K |
| 86 | SNAPSNAP INC | CL A | 0.34% | $213,000 | 5.9K |
| 87 | ORTHO CLINICAL DIAGNOSTICS H | ORD SHS | 0.32% | $205,000 | 11.0K |
| 88 | MUMICRON TECHNOLOGY INC | COM | 0.32% | $203,000 | 2.6K |
| 89 | FUTURE HEALTH ESG CORP | COM · *W EXP 99/99/999 | 0.32% | $203,000 | 164.5K |
| 90 | MANDIANT INC | COM | 0.32% | $201,000 | 9.0K |
| 91 | HUMANIGEN INC | COM NEW | 0.32% | $200,000 | 66.5K |
| 92 | BELLEROPHON THERAPEUTICS INC | COM NEW | 0.31% | $197,000 | 83.6K |
| 93 | GLOBALSTAR INC | COM | 0.30% | $191,000 | 130.0K |
| 94 | VERASTEM INC | COM | 0.30% | $190,000 | 135.0K |
| 95 | TRACON PHARMACEUTICALS INC | COM NEW | 0.28% | $176,000 | 67.0K |
| 96 | KORE GROUP HOLDINGS INC | COMMON STOCK · *W EXP 99/99/999 | 0.28% | $175,000 | 78.0K |
| 97 | SNDXSYNDAX PHARMACEUTICALS INC | COM | 0.27% | $174,000 | 10.0K |
| 98 | TALKTALKSPACE INC | COM | 0.23% | $148,000 | 85.0K |
| 99 | MONEYLION INC | CL A · *W EXP 09/22/202 | 0.23% | $147,000 | 161.7K |
| 100 | ALLOT LTD | SHS | 0.21% | $130,000 | 16.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2022 | Under review | 146 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $78M | 177 | Nov 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $84M | 177 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $63M | 165 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $78M | 178 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $74M | 160 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $73M | 139 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $88M | 126 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $59M | 89 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $46M | 73 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $37M | 65 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $29M | 54 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $30M | 41 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $35M | 53 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $129M | 82 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $197M | 101 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $157M | 136 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.